Cosmos Pharmaceutical Corp - Net Income

Cosmos Pharmaceutical Corp's Fiscal Year is From June To May - All Figures are in JPY, Billions.

The item "Net-Income" stands at 30.98 Billion Japanese Yens for the trailing twelve months (TTM) period ending 05/31/2025, the highest value at least since 11/30/2011, the period currently displayed.

Cosmos Pharmaceutical Corp's fourth quarter result of 8.64 Billion JPY for the item "Net Income" represents an increase of 9.10 percent compared to it's third quarter result.

Also, Cosmos Pharmaceutical Corp's fourth quarter result of 8.64 Billion JPY for the item "Net Income" represents an increase of 21.67 percent compared to it's fourth quarter result of last year.

Looking again at the trailing twelve months series (TTM), Cosmos Pharmaceutical Corp's fourth quarter result of 30.98 Billion JPY for the item "Net Income" represents an increase of 5.22 percent compared to it's third quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.68 percent compared to the value the year prior.
The 1 year change in percent is 26.68.
The 3 year change in percent is 33.79.
The 5 year change in percent is 44.52.
The 10 year change in percent is 164.91.

The Serie's long term average value is 17.72 Billion Japanese Yens. It's latest available value, on 05/31/2025, is 74.79 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 08/31/2011, to it's latest available value, on 05/31/2025, is +375.41%.
The Serie's change in percent from it's maximum value, on 05/31/2025, to it's latest available value, on 05/31/2025, is 0.0%.